Stage

Treatment of Primary Lesion

Initial Systemic Workup

Workup and treatment for SLN

Workup and treatment for palpable LN

Workup and treatment for LR

Workup and Tx for in-transit metastases

Workup and treatment for metastatic disease

5-year Surveillance

Patient time costs

Terminal care costs

In situ

2,434.88

0

0

0

422.07

0

0

1,240.00

551.34

0

IA

2,684.25

0

624.84

0

27.90

139.50

2,442.18

3,759.00

1,132.80

304.50

IB

2,791.12

140.00

1,675.00

0

91.86

277.30

7,582.38

5,166.00

1,765.33

945.40

IIA

2,897.99

140.00

3,000.50

0

301.60

628.30

14,525.14

5,794.00

2,359.47

1,811.05

IIB

3,379.86

140.00

5,064.58

0

510.80

789.70

35,318.54

6,029.00

3,741.87

4,403.65

IIC

3,486.73

140.00

5,296.30

0

819.30

785.40

83,731.80

6,678.00

6,750.93

10,440.00

IIIA

3,486.73

140.00

6,962.40

0

974.50

2369.30

77,684.51

42,525.84

6,808.53

9,686.00

IIIB

3,531.26

10,333.00

6,004.20

1,599.70

1,281.75

1491.80

78,382.28

50,566.44

7,161.60

9,773.00

IIIC

3,531.26

13,836.00

5,514.40

2,714.70

1,737.90

11320

89,197.64

50,566.44

7,542.93

11,121.50

IV

3,531.26

15,336.00

1,408.70

1,615.90

0

0

116,294.20

0

7,122.13

14,500.00